Causes of Hypercalcemia
Hypercalcemia is fundamentally divided into two categories based on PTH levels: PTH-dependent (elevated or inappropriately normal PTH) and PTH-independent (suppressed PTH), with primary hyperparathyroidism and malignancy accounting for 80-90% of all cases 1, 2.
Algorithmic Approach to Etiology
The diagnostic framework hinges on measuring serum PTH, which immediately stratifies causes into two distinct pathways:
PTH-Dependent Hypercalcemia (Elevated or Normal PTH)
Primary hyperparathyroidism (PHPT) is the leading ambulatory cause of hypercalcemia 2, 3. This results from autonomous PTH secretion, typically from a parathyroid adenoma, causing increased bone resorption and intestinal calcium absorption through elevated calcitriol production 1.
Familial hypocalciuric hypercalcemia (FHH) presents with inappropriately normal PTH despite hypercalcemia, caused by inactivating mutations in the calcium-sensing receptor gene (CASR) or other related genes 1.
Parathyroid carcinoma is a rare but critical PTH-dependent cause, often presenting with markedly elevated calcium levels and requiring aggressive management 4.
PTH-Independent Hypercalcemia (Suppressed PTH <20 pg/mL)
According to the most recent 2025 guidelines, six main etiologic categories exist when PTH is suppressed 1:
1. Malignancy-Related (Most Common in Hospitalized Patients)
Humoral hypercalcemia of malignancy: PTH-related peptide (PTHrP) secretion from solid tumors (epidermoid, neuroendocrine) activates PTH receptors, causing bone resorption with characteristic hypophosphatemia that distinguishes it from osteolytic disease 1
Local osteolytic hypercalcemia: Direct bone destruction from metastases (breast cancer) or myeloma through cytokine-mediated osteoclast activation, typically with hyperphosphatemia 1
2. Vitamin D-Related
Hypervitaminosis D from excessive calcitriol production occurs via:
- Granulomatous diseases (sarcoidosis) where macrophages produce unregulated 1-alpha-hydroxylase 1
- Lymphomas with similar mechanisms 1
- Exogenous vitamin D intoxication 2
These conditions show elevated phosphate due to increased intestinal phosphate absorption 1.
3. Genetic Causes
Multiple rare genetic syndromes present with PTH-independent hypercalcemia 1:
- Childhood idiopathic hypercalcemia type 1: CYP24A1 gene mutations impairing vitamin D catabolism
- Williams-Beuren syndrome: Chromosome 7 microdeletion causing infantile hypercalcemia (15% of cases)
- Jansen's metaphyseal chondrodysplasia: Activating PTH1R mutations (hypercalcemia typically ages 1 month-10 years)
- Hypophosphatasia: ALPL gene mutations with hypercalcemia, hyperphosphatemia, and low alkaline phosphatase
4. Immobilization
Occurs 4-6 weeks after immobilization onset, particularly in young adults post-spinal cord trauma or elderly poly-pathological patients. Mechanism involves increased sclerostin inhibiting the Wnt pathway, causing predominant osteoclastic resorption 1.
5. Endocrinopathies
- Hyperthyroidism: Direct thyroid hormone action on bone resorption 1
- Acute adrenal insufficiency: Hypercalcemia <3 mmol/L from dehydration and metabolic acidosis 1
- Pheochromocytoma: Catecholamine effects on bone or PTHrP secretion 1
- Acromegaly: IGF-1-mediated calcitriol production causing hypercalcemic tendency 1
6. Drug-Induced
- Thiazide diuretics 2
- Lithium 5
- Calcium and vitamin D supplements 2
- Vitamin A toxicity 2
- Milk-alkali syndrome 5
7. Cirrhosis
Chronic or acute liver decompensation causes hypercalcemia through inflammatory cytokine and prostaglandin release, associated with increased mortality 1.
Critical Clinical Pitfalls
Do not rely on corrected calcium alone—ionized calcium is the active form and should be measured when available, as total calcium calculations are frequently inaccurate 5.
Hypophosphatemia vs. hyperphosphatemia is diagnostically crucial: PTHrP-mediated malignancy causes hypophosphatemia, while osteolytic metastases cause hyperphosphatemia 1.
Vitamin D deficiency masks PHPT severity by limiting calcitriol production and reducing intestinal calcium absorption, potentially normalizing urinary calcium despite underlying hyperparathyroidism 1.
Recent associations include sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, denosumab discontinuation, SARS-CoV-2, ketogenic diets, and extreme exercise, though these account for <1% of cases 2.